Marie-Cecile PLOY, PharmD, PhD, is a Professor of Microbiology at the Faculty of Medicine and Limoges Teaching Hospital, Limoges University, France. She is head of the Bacteriology-virology-hygiene department at the Limoges teaching hospital and director of the Inserm RESINFIT research unit on antimicrobials at the Limoges University (https://www.unilim.fr/resinfit/). She gained her PharmD in 1994 and her PhD on aminoglycoside resistance in 2000 (Institut Pasteur and Paris XI University). She had a postdoctoral position (2003-2004) in Didier Mazel’lab at the Institut Pasteur in Paris, France, where she focused her research on integrons.
She is part of numerous Committees on Antimicrobial resistance at the national level. She was the coordinator of the European Joint Action an Antimicrobial resistance and healthcare-associated infections (www.eu-jamrai.eu) from 2017 to 2021 and she coordinates the second Joint action, EU-JAMRAI 2, from 2024 to 2027.
She is an expert in numerous national and international research programmes on antimicrobial resistance.
She is vice-dean for research at the Faculty of Medicine, Limoges University
She is full member of the French Academy for Veterinary Medicine
Her research addresses the mechanisms and dynamics of mobilization and spread of antimicrobial resistance. Her main research topics are i) the role of the SOS response in antibiotic resistance acquisition and expression, and ii) the risk assessment of the antibiotic resistance dissemination in the environment.
